AFP464 in Treating Patients With Advanced Solid Tumors
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of AFP464 in treating patients
with advanced solid tumors. Drugs used in chemotherapy, such as AFP464, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing.